US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Sales | 40 | 58 | 309 | 157 | 1,298 |
| Cost of Goods | 17 | 18 | 170 | 137 | 506 |
| Gross Profit | 23 | 39 | 139 | 19 | 792 |
| Operating Expenses | 508 | 556 | 1,195 | 1,754 | 1,832 |
| Operating Income | -469 | -498 | -886 | -1,598 | -534 |
| Interest Expense | 105 | 82 | 130 | 91 | 365 |
| Other Income | 4 | 4 | 339 | 43 | 60 |
| Pre-tax Income | -569 | -576 | -677 | -1,646 | -839 |
| Net Income Continuous | -569 | -576 | -677 | -1,646 | -839 |
| Net Income | $-569 | $-576 | $-677 | $-1,646 | $-839 |
| EBITDA(a) | $-378 | $-423 | $-741 | $-1,499 | $-418 |